<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Slbtgroup]]></title><description><![CDATA[Slbtgroup]]></description><link>https://www.slbtgroup.com/newsroom</link><generator>RSS for Node</generator><lastBuildDate>Fri, 12 Jun 2026 15:27:49 GMT</lastBuildDate><atom:link href="https://www.slbtgroup.com/zh/blog-feed.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[SL Science 王慶棟董事長以打造無癌世界為願景，毅然轉戰生技產業]]></title><description><![CDATA[SLBT Group 王慶棟董事長因父親罹患胰臟癌的親身經歷，立志打造「無癌世界」，毅然從半導體產業跨足生技領域。他帶領團隊研發先進細胞治療技術，並創辦癌症研究基金會，迄今已協助逾千名患者，以創新與無私奉獻的精神，全力推動癌症治療的革新。]]></description><link>https://www.slbtgroup.com/zh/post/slbt-group-william-wang-cancer-free-world-biotech-2024-06</link><guid isPermaLink="false">6a043b8907790403586815c6</guid><category><![CDATA[新聞]]></category><pubDate>Wed, 13 May 2026 09:46:17 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/080b3e_16007355e06449ababe05fa3a3705642~mv2.jpg/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>doublechen0</dc:creator></item><item><title><![CDATA[SL Science 聚焦創新突破，全力投入癌症治療研究]]></title><description><![CDATA[SL Science Holding Limited（SLBT Group，追日潤生技）王慶棟董事長，憑藉超過十年半導體產業的精密技術底蘊，毅然跨足生技領域，全力投入癌症治療研究。他帶領台灣生技與醫療團隊，積極研發先進細胞治療技術，致力取代傳統化療、降低治療副作用與成本，讓更多患者獲得有效的抗癌療法，改寫人們對癌症的恐懼與絕望。]]></description><link>https://www.slbtgroup.com/zh/post/zh-sl-science-cancer-research-2024-10</link><guid isPermaLink="false">6a04349d0d8273e65563e5ae</guid><category><![CDATA[新聞]]></category><pubDate>Wed, 13 May 2026 08:46:21 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/f76537_ed3f7ef1675747f4b3343690813f2bc5~mv2.jpg/v1/fit/w_600,h_340,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>doublechen0</dc:creator></item><item><title><![CDATA[SL Science focuses on innovation and breakthroughs, with a strong commitment to cancer treatment research]]></title><description><![CDATA[SLBT Group (SL Science Holding Limited) Chairman William Wang leverages decades of semiconductor expertise to pioneer advanced cell therapy in Taiwan, aiming to replace chemotherapy, reduce treatment costs, and redefine how the world confronts cancer.]]></description><link>https://www.slbtgroup.com/post/sl-science-cancer-treatment-research-innovation</link><guid isPermaLink="false">6965d52c39b48a2326f3ea72</guid><category><![CDATA[News]]></category><pubDate>Wed, 09 Oct 2024 16:00:00 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/f76537_ed3f7ef1675747f4b3343690813f2bc5~mv2.jpg/v1/fit/w_600,h_340,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>cgliu34</dc:creator></item><item><title><![CDATA[SL Science's founder and chairman, William Wang, has shifted his focus to the biotech industry, driven by a vision to create a world free of cancer]]></title><description><![CDATA[Date: June 22, 2024 According to Taiwan's Ministry of Health and Welfare, cancer ranks as the leading cause of death in the country. There are many people having had to abandon promising careers, lives, and families due to this disease. SL Science’s chairman, William Wang, understands this deeply. The sudden passing of his father, who had only a few months between a pancreatic cancer diagnosis and his death, left him unprepared and filled with sorrow. As a family member affected by cancer, he...]]></description><link>https://www.slbtgroup.com/post/hexun-biosciences-partners-with-jy-biomedical-to-sign-a-technology-licensing-agreement-with-a-total</link><guid isPermaLink="false">6965d52c39b48a2326f3ea65</guid><category><![CDATA[News]]></category><pubDate>Sat, 22 Jun 2024 06:39:38 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/080b3e_16007355e06449ababe05fa3a3705642~mv2.jpg/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>cgliu34</dc:creator></item></channel></rss>